[go: up one dir, main page]

NO20060416L - New use I - Google Patents

New use I

Info

Publication number
NO20060416L
NO20060416L NO20060416A NO20060416A NO20060416L NO 20060416 L NO20060416 L NO 20060416L NO 20060416 A NO20060416 A NO 20060416A NO 20060416 A NO20060416 A NO 20060416A NO 20060416 L NO20060416 L NO 20060416L
Authority
NO
Norway
Prior art keywords
promotion
inhibitor
wound healing
new use
had1
Prior art date
Application number
NO20060416A
Other languages
Norwegian (no)
Inventor
Cecilia Nilsson
Catrine Dreifeldt
Original Assignee
Biovitrum Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biovitrum Ab filed Critical Biovitrum Ab
Publication of NO20060416L publication Critical patent/NO20060416L/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/426—1,3-Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)

Abstract

Metode for promotering av sårheling, innbefattende administrasjon til et pattedyr, inkludert menneske, som har behov for slik promotering, av en effektiv mengde av en inhibitor av 11-(-hydroksysteroid dehydrogenase type I, hvor nevnte 11(-HAD1-inhibitor har formelen (I): hvor T, B, X, Y, R1 og R2 er som definert i beskrivelse og krav. Disse forbindelsene kan også anvendes i fremstillingen av et medikament for promotorering av sårheling.A method of promoting wound healing, including administration to a mammal, including human, in need of such promotion, of an effective amount of an inhibitor of 11 - (- hydroxysteroid dehydrogenase type I, wherein said 11 (-HAD1 inhibitor has the formula ( I): wherein T, B, X, Y, R 1 and R 2 are as defined in the description and claims, these compounds can also be used in the preparation of a medicament for the promotion of wound healing.

NO20060416A 2003-06-25 2006-01-25 New use I NO20060416L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE0301882A SE0301882D0 (en) 2003-06-25 2003-06-25 New use I
PCT/SE2004/000996 WO2004112784A1 (en) 2003-06-25 2004-06-21 New use i

Publications (1)

Publication Number Publication Date
NO20060416L true NO20060416L (en) 2006-03-24

Family

ID=27656617

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20060416A NO20060416L (en) 2003-06-25 2006-01-25 New use I

Country Status (9)

Country Link
EP (1) EP1638553A1 (en)
JP (1) JP2007521264A (en)
KR (1) KR20060023570A (en)
CN (1) CN1812784A (en)
AU (1) AU2004249099A1 (en)
CA (1) CA2529406A1 (en)
NO (1) NO20060416L (en)
SE (1) SE0301882D0 (en)
WO (1) WO2004112784A1 (en)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR049344A1 (en) 2004-05-24 2006-07-19 Amgen Inc INHIBITORS OF THE 11-BETA-HYDROXI STEROID DEHYDROGENASE TYPE 1
US8686011B2 (en) 2004-05-24 2014-04-01 Amgen Inc. Inhibitors of 11-β-hydroxy steroid dehydrogenase type 1
GB0506133D0 (en) * 2005-03-24 2005-05-04 Sterix Ltd Compound
JP5140577B2 (en) 2005-03-31 2013-02-06 タケダ カリフォルニア インコーポレイテッド Hydroxysteroid dehydrogenase inhibitor
US7622492B2 (en) 2005-08-31 2009-11-24 Hoffmann-La Roche Inc. Pyrazolones as inhibitors of 11β-hydroxysteroid dehydrogenase
MX2008006530A (en) 2005-11-22 2008-09-25 Amgen Inc Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1.
CA2666193A1 (en) 2006-08-08 2008-02-14 Sanofi-Aventis Arylaminoaryl-alkyl-substituted imidazolidine-2,4-diones, process for preparing them, medicaments comprising these compounds, and their use
JP5098011B2 (en) * 2006-11-20 2012-12-12 国立大学法人山口大学 Wound healing promoter
DE102007005045B4 (en) 2007-01-26 2008-12-18 Sanofi-Aventis Phenothiazine derivatives, process for their preparation and their use as medicines
JP5463285B2 (en) * 2007-07-13 2014-04-09 アイカジェン， インコーポレイテッド Sodium channel inhibitor
EP2025674A1 (en) 2007-08-15 2009-02-18 sanofi-aventis Substituted tetra hydro naphthalines, method for their manufacture and their use as drugs
AR072707A1 (en) 2008-07-09 2010-09-15 Sanofi Aventis HETEROCICLIC COMPOUNDS, PROCESSES FOR THEIR PREPARATION, DRUGS THAT UNDERSTAND THESE COMPOUNDS AND THE USE OF THEM
WO2010068601A1 (en) 2008-12-08 2010-06-17 Sanofi-Aventis A crystalline heteroaromatic fluoroglycoside hydrate, processes for making, methods of use and pharmaceutical compositions thereof
AU2010288523A1 (en) 2009-08-26 2012-03-15 Sanofi Novel crystalline heteroaromatic fluoroglycoside hydrates, pharmaceuticals comprising these compounds and their use
WO2011107494A1 (en) 2010-03-03 2011-09-09 Sanofi Novel aromatic glycoside derivatives, medicaments containing said compounds, and the use thereof
US8933024B2 (en) 2010-06-18 2015-01-13 Sanofi Azolopyridin-3-one derivatives as inhibitors of lipases and phospholipases
US8530413B2 (en) 2010-06-21 2013-09-10 Sanofi Heterocyclically substituted methoxyphenyl derivatives with an oxo group, processes for preparation thereof and use thereof as medicaments
TW201221505A (en) 2010-07-05 2012-06-01 Sanofi Sa Aryloxyalkylene-substituted hydroxyphenylhexynoic acids, process for preparation thereof and use thereof as a medicament
TW201215387A (en) 2010-07-05 2012-04-16 Sanofi Aventis Spirocyclically substituted 1,3-propane dioxide derivatives, processes for preparation thereof and use thereof as a medicament
TW201215388A (en) 2010-07-05 2012-04-16 Sanofi Sa (2-aryloxyacetylamino)phenylpropionic acid derivatives, processes for preparation thereof and use thereof as medicaments
EP2683700B1 (en) 2011-03-08 2015-02-18 Sanofi Tetra-substituted oxathiazine derivatives, method for their preparation, their usage as medicament and medicament containing same and its use
EP2683702B1 (en) 2011-03-08 2014-12-24 Sanofi New substituted phenyl oxathiazine derivatives, method for their manufacture, medicines containing these compounds and their application
US8809325B2 (en) 2011-03-08 2014-08-19 Sanofi Benzyl-oxathiazine derivatives substituted with adamantane and noradamantane, medicaments containing said compounds and use thereof
US8828994B2 (en) 2011-03-08 2014-09-09 Sanofi Di- and tri-substituted oxathiazine derivatives, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof
US8828995B2 (en) 2011-03-08 2014-09-09 Sanofi Branched oxathiazine derivatives, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof
EP2683699B1 (en) 2011-03-08 2015-06-24 Sanofi Di- and tri-substituted oxathiazine derivates, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof
EP2683701B1 (en) 2011-03-08 2014-12-24 Sanofi Oxathiazine derivatives substituted with benzyl or heteromethylene groups, method for their preparation, their usage as medicament, medicament containing same and its use
EP2766349B1 (en) 2011-03-08 2016-06-01 Sanofi Oxathiazine derivatives substituted with carbocycles or heterocycles, method for producing same, drugs containing said compounds, and use thereof
WO2012120057A1 (en) 2011-03-08 2012-09-13 Sanofi Novel substituted phenyl-oxathiazine derivatives, method for producing them, drugs containing said compounds and the use thereof
WO2013037390A1 (en) 2011-09-12 2013-03-21 Sanofi 6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
WO2013045413A1 (en) 2011-09-27 2013-04-04 Sanofi 6-(4-hydroxy-phenyl)-3-alkyl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
CN103204824B (en) * 2012-01-12 2015-04-08 清华大学深圳研究生院 2-aminothiazole-4-amide derivative, its preparation method and application
TW201512171A (en) 2013-04-19 2015-04-01 Pfizer Ltd Chemical compounds
CN105061288B (en) * 2015-08-07 2017-09-15 武汉华素康生物科技有限公司 Compound and its preparation method and application
EP3235813A1 (en) 2016-04-19 2017-10-25 Cidqo 2012, S.L. Aza-tetra-cyclo derivatives
CN118340765B (en) * 2024-04-30 2024-08-23 广州市朝利良生物科技有限公司 Application of benzamide compound in preparation of wound healing promoting medicine

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH10639A (en) * 1967-07-17 1977-07-22 Research Corp Method of treatment and composition containing silver sulfadiazine
CN1130355C (en) * 1995-04-04 2003-12-10 德州生物科技公司 Thienyl-, Furyl-, Pyrrolyl- and biphenylsulfonamides and derivatives thereof that modulate the activity of endothelin
IL129148A0 (en) * 1996-10-16 2000-02-17 American Cyanamid Co The preparation and use of ortho-sulfonamide aryl hydroxamic acids as matrix metalloproteinase and tace inhibitors
SE0001899D0 (en) * 2000-05-22 2000-05-22 Pharmacia & Upjohn Ab New compounds

Also Published As

Publication number Publication date
KR20060023570A (en) 2006-03-14
EP1638553A1 (en) 2006-03-29
CN1812784A (en) 2006-08-02
JP2007521264A (en) 2007-08-02
CA2529406A1 (en) 2004-12-29
AU2004249099A1 (en) 2004-12-29
SE0301882D0 (en) 2003-06-25
WO2004112784A1 (en) 2004-12-29

Similar Documents

Publication Publication Date Title
NO20060416L (en) New use I
SE0301886D0 (en) New use V
SE0301888D0 (en) New use VII
TR200103493T2 (en) Metalloprotease inhibitors
NO20025601D0 (en) Arylmethylamine derivatives for use as tryptase inhibitors
NO20055863L (en) W-carboxyaryl-substituted diphenylurea compounds as raf kinase inhibitors
SE0101387D0 (en) Novel compounds
NO972538L (en) New sulfonamides
NO20064347L (en) Substituted 1,2,3,4-tetrahydroisoquinoline derivatives
BG108181A (en) NEW SPIRITORCYCLE DERIVATIVES AND THEIR USE AS INHIBITORS OF PHOSPHODIESTERASE-7
EA200501268A1 (en) HIV-Inhibiting 1,2,4-TRIAZINS
ATE344029T1 (en) TREATING TYPE II DIABETES WITH DIPEPTIDYL PEPTIDASE IV INHIBITORS
SG166791A1 (en) Novel macrocyclic inhibitors of hepatitis c virus replication
DK1411932T3 (en) Combination therapy with substituted oxazolidinones
NO20083005L (en) Use of benzofused heterocyclic sulfamide derivatives for the treatment of pain
ATE373474T1 (en) SUBSTITUTED 2-AMINOTETRALINE FOR THE TREATMENT OF DEPRESSION
NO20065904L (en) Therapeutic compounds
SE9900961D0 (en) Novel compounds
SE0203304D0 (en) Novel Coumpounds
DE60121804D1 (en) PHARMACEUTICAL COMPOSITION OF A BIGUANINE (METFORMIN) AND ARGININE
HUP0200152A2 (en) Utilization of inhibitors of the kqt1 channel in order to produce a medicament for treating diseases which are caused by parasitic helminths and ectoparasites
SE0004101D0 (en) New use
SE0301883D0 (en) New use II
SE0301885D0 (en) New use IV
SE0301884D0 (en) New use III

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application